Results 321 to 330 of about 204,414 (356)
Nuclear receptors and disease: androgen receptor [PDF]
The androgen receptor (AR) protein regulates transcription of certain genes. Usually this depends upon a central DNA-binding domain that permits the binding of androgen–AR complexes to regulatory DNA sequences near or in a target gene. The AR also has a C-terminal ligand-binding domain and an Nterminal transcription modulatory domain.
Jianhui Wu+8 more
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Androgen receptor polymorphism (CAG repeats) and androgenicity
Clinical Endocrinology, 2005SummaryObjective Polymorphism of the androgen receptor (AR) has been related to various pathophysiological conditions, such as osteoporosis and infertility. The objectives of this study were to evaluate the frequency of distribution in a normal Italian population and to assess CAG repeats (CAGr) in other conditions, such as hypoandrogenism ...
CANALE D+6 more
openaire +4 more sources
2019
Androgens and the androgen receptor (AR) play crucial roles in the biology of normal and diseased prostate tissue, including prostate cancer (PCa). This dependence is evidenced by the use of androgen depletion therapy (ADT) as the primary treatment for locally advanced, metastatic, or relapsed PCa.
Aashi Chaturvedi, Scott M. Dehm
openaire +3 more sources
Androgens and the androgen receptor (AR) play crucial roles in the biology of normal and diseased prostate tissue, including prostate cancer (PCa). This dependence is evidenced by the use of androgen depletion therapy (ADT) as the primary treatment for locally advanced, metastatic, or relapsed PCa.
Aashi Chaturvedi, Scott M. Dehm
openaire +3 more sources
[12] Trafficking of the androgen receptor
1999Publisher Summary The androgen receptor (AR) belongs to the superfamily of nuclear receptors characterized by a common structure and mechanism of action. The AR is an androgen-dependent transcription factor composed of four domains: the amino-terminal transcription activation domain; the DNA-binding domain, which interacts with a specific DNA ...
Jean-Claude Nicolas+3 more
openaire +3 more sources
Androgen Receptor and Estrogen Receptors
2002The androgen receptor (AR) and the estrogen receptors (ER) are members of the nuclear receptor (NR) family. These NRs are distinguished from the other transcription factors by their ability to control gene expression upon ligand binding (steroids, retinoids, thyroid hormone, vitamin D, fatty acids, and other small hydrophobic molecules). Their combined
H. M. Oosterkamp, R. Bernards
openaire +2 more sources
Androgens and androgen receptor in prostate and ovarian malignancies
Frontiers in Bioscience, 2003The molecular and biochemical mechanisms contributing to the development and progression of both prostate and ovarian carcinogenesis are currently unknown. A better understanding of the cross-talk between endocrine, signal transduction and regulatory pathways in normal and neoplastic prostatic and ovarian tissues is necessary to elucidate malignant ...
Marianne D. Sadar, Katie Meehan
openaire +3 more sources
Androgen dependency of the androgen receptor in rat epididymis
Biochemical and Biophysical Research Communications, 1975Abstract Binding of radioactive androgen to the 8S epididymal receptor is reduced to undetectable levels after 30 days of castration. Testosterone propionate(200 μg/day)administered starting immediately after castration and continued for 30 days prevented the disappearance of binding activity.
Ricardo S. Calandra+3 more
openaire +3 more sources
The role of androgens and the androgen receptor in prostate cancer
Cancer Letters, 2002Prostate cancer (PCa) is the leading diagnosed malignancy in men in western countries. The relationship between androgens and the androgen receptor (AR) has been studied extensively in PCa. Plasma levels of androgens show variations between different populations, and in many cases this correlates with PCa susceptibility.
Donald J. Tindall, Jose D. Debes
openaire +3 more sources
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-vornhagen+2 more
exaly